Stay updated on Orally Administered AG-120 in Hematologic Malignancies Clinical Trial
Sign up to get notified when there's something new on the Orally Administered AG-120 in Hematologic Malignancies Clinical Trial page.

Latest updates to the Orally Administered AG-120 in Hematologic Malignancies Clinical Trial page
- Check3 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedThe page history shows the latest revision updated to v3.6.3, replacing the previous v3.6.2. This reflects a minor update to the page's version rather than changes to study details.SummaryDifference0.1%

- Check25 days agoChange DetectedA new site revision entry v3.6.2 was added to the history, and the previous entry v3.6.0 was removed. This represents a minor background release update to the site rather than changes to the study data or public study information.SummaryDifference0.1%

- Check32 days agoChange DetectedA new 'Study Status' entry was added to the record history with associated date markers (2026-06-15 and 2026-06-11) and the value 50, while the existing entry from 2025-06-08 was deleted, updating the history timeline to reflect the latest status information.SummaryDifference0.2%

- Check39 days agoChange DetectedNew quick-access links for joining eligibility and contact information were added to the study record history page, and the site revision was updated from v3.5.5 to v3.6.0.SummaryDifference0.3%

- Check47 days agoChange DetectedThe page footer revision tag was updated from v3.5.4 to v3.5.5, signaling a new build of the page. This change does not alter study data or visible content beyond the version tag.SummaryDifference0.1%

- Check68 days agoChange DetectedA new revision entry 'Revision: v3.5.4' was added to the record history and the previous 'Revision: v3.5.3' entry was removed, indicating an update to the site's version reflected in the history log.SummaryDifference0.1%

Stay in the know with updates to Orally Administered AG-120 in Hematologic Malignancies Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Orally Administered AG-120 in Hematologic Malignancies Clinical Trial page.